GlassScriptPhysician profile
Joan Bergstrom
NPI 1396727814
$634.50
in general payments reported to CMS, 2019-2025
16 companies · $208 in 2025
The $208 reported for 2025 was more than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.58 · 2020: $43.19 · 2021: $106 · 2022: $61.12 · 2023: $121 · 2024: $64.45 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $393.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $190.46 | 2021-2023 | Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $183.80 | 2024-2025 | Myosure Tissue Removal Device |
| Boston Scientific Corporation | $36.53 | 2025 | Varithena Administration Pack |
| Astellas Pharma US INC | $33.28 | 2023-2024 | Veozah |
| Evofem Biosciences, INC. | $25.79 | 2021 | |
| Innovation Technologies INC | $23.82 | 2023 | Irrisept |
| Ascend Therapeutics US, LLC | $21.47 | 2024 | |
| Organon LLC | $16.82 | 2025 | Nexplanon |
| Allergan, INC. | $16.70 | 2019 | |
| Avion Pharmaceuticals | $15.75 | 2020 | |
| Minerva Surgical, INC | $14.50 | 2023 | |
| Aspira Women'S Health INC | $14.26 | 2023 | Ova1 |
| Coopersurgical, INC. | $14.21 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.88 | 2019 | |
| Merck Sharp & Dohme LLC | $13.23 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joan Bergstrom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.